Milnacipran inhibits glutamatergic <it>N</it>-Methyl-D-Aspartate receptor activity in Spinal Dorsal Horn Neurons
<p>Abstract</p> <p>Background</p> <p>Antidepressants, which are widely used for treatment of chronic pain, are thought to have antinociceptive effects by blockade of serotonin and noradrenaline reuptake. However, these drugs also interact with various receptors such as...
Main Authors: | Kohno Tatsuro, Kimura Masafumi, Sasaki Mika, Obata Hideaki, Amaya Fumimasa, Saito Shigeru |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2012-06-01
|
Series: | Molecular Pain |
Subjects: | |
Online Access: | http://www.molecularpain.com/content/8/1/45 |
Similar Items
-
Glutamatergic Dysfunction and Glutamatergic Compounds for Major Psychiatric Disorders: Evidence From Clinical Neuroimaging Studies
by: Cheng-Ta Li, et al.
Published: (2019-01-01) -
The Emerging Role of Altered d-Aspartate Metabolism in Schizophrenia: New Insights From Preclinical Models and Human Studies
by: Francesco Errico, et al.
Published: (2018-11-01) -
Human D-aspartate Oxidase: A Key Player in D-aspartate Metabolism
by: Loredano Pollegioni, et al.
Published: (2021-06-01) -
Dorsal hippocampal N-methyl-d-aspartate glutamatergic and δ-opioidergic systems modulate anxiety behaviors in rats in a noninteractive manner
by: Jalal Solati
Published: (2011-11-01) -
Impact of psychotomimetic molecules on glutamatergic N-Methyl-D-Aspartate receptors surface trafficking
by: Jezequel, Julie
Published: (2016)